Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reaction identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse [8]

Blood

Volumn 96, Issue 4, 2000, Pages 1619-1620

  De Haas, V ^a   Breunis, W B ^a   Verhagen, O J ^a   Van den Berg, H ^a   Van der Schoot, C E ^a  

^a Department of Immunohematology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILD; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; HIGH RISK POPULATION; HUMAN; IMMUNOPHENOTYPING; LETTER; LEUKEMIA REMISSION; LEUKEMOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RELAPSE;

EID: 0034663165     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.4.1619     Document Type: Letter

References (3)

1. Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia
2. Application of germline IGH-probes in real-time quantitative PCR for the detection of minimal residual disease in acute lumphoblastic leukemia
3. Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood